Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tables, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

  Recent Press Releases:

7/2/2010	Elite Pharmaceuticals, Inc. Announces 2010 Fourth Quarter and Year-End Investor Conference Call on Thursday, July 8, 2010
6/30/2010	ELITE ANNOUNCES SETTLEMENT OF LITIGATION
5/24/2010	ELITE PHARMACEUTICALS ANNOUNCES ACQUISITION OF GENERIC HYDROMORPHONE PRODUCT
2/22/2010	Elite Pharmaceuticals, Inc. 3rd Quarter 2010 Financial Results …Revenue increased 287% for the comparable period of the prior year
2/16/2010	Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call on Friday, February 19, 2010